Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roger, F.
Right arrow Articles by Féraille, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roger, F.
Right arrow Articles by Féraille, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 48, 34103-34110, November 26, 1999


Cell Shrinkage Triggers the Activation of Mitogen-activated Protein Kinases by Hypertonicity in the Rat Kidney Medullary Thick Ascending Limb of the Henle's Loop
REQUIREMENT OF p38 KINASE FOR THE REGULATORY VOLUME INCREASE RESPONSE*

Frank Roger, Pierre-Yves Martin, Martine Rousselot, Hervé Favre, and Eric FérailleDagger

From the Division de Néphrologie, Fondation pour Recherches Médicales, 64 Ave de la Roseraie, CH-1211 Genève 4, Switzerland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The kidney medulla is exposed to very high interstitial osmolarity leading to the activation of mitogen-activated protein kinases (MAPK). However, the respective roles of increased intracellular osmolality and of cell shrinkage in MAPK activation are not known. Similarly, the participation of MAPK in the regulatory volume increase (RVI) following cell shrinkage remains to be investigated. In the rat medullary thick ascending limb of Henle (MTAL), extracellular hypertonicity produced by addition of NaCl or sucrose increased the phosphorylation level of extracellular signal-regulated kinase (ERK) and p38 kinase and to a lesser extent c-Jun NH2-terminal kinase with sucrose only. Both hypertonic solutions decreased the MTAL cellular volume in a dose- and time-dependent manner. In contrast, hypertonic urea had no effect. The extent of MAPK activation was correlated with the extent of MTAL cellular volume decrease. Increasing intracellular osmolality without modifying cellular volume did not activate MAPK, whereas cell shrinkage without variation in osmolality activated both ERK and p38. In the presence of 600 mosmol/liter NaCl, the maximal cell shrinkage was observed after 10 min at 37 °C and the MTAL cellular volume was reduced to 70% of its initial value. Then, RVI occurred and the cellular volume progressively recovered to reach about 90% of its initial value after 30 min. SB203580, a specific inhibitor of p38, almost completely inhibited the cellular volume recovery, whereas inhibition of ERK did not alter RVI. In conclusion, in rat MTAL: 1) cell shrinkage, but not intracellular hyperosmolality, triggers the activation of both ERK and p38 kinase in response to extracellular hypertonicity; and 2) RVI is dependent on p38 kinase activation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

During diuresis and antidiuresis, the kidney medulla is exposed to large fluctuations of interstitial osmolarity (1), which challenge cell volume constancy. Cells of the medullary thick ascending limb of Henle (MTAL)1 are of special interest, since they are the major contributor to the generation of the renal cortico-papillary osmotic gradient allowing urinary concentration in terrestrial animals. The first adaptive process occurring in response to extracellular hypertonicity-induced cell shrinkage is a regulatory cell volume increase (RVI). The RVI results from the stimulation of ion transporters which increase the intracellular ion content within minutes and partially restore the cellular volume from the initial cell shrinkage (2, 3). A second adaptive mechanism, in mammalian cells, is the induction of genes encoding proteins involved in the accumulation of intracellular "compatible osmolytes" within hours and days. These osmoprotective proteins are either enzymes, i.e. aldose reductase generating sorbitol from glucose, or organic osmolytes transporters, i.e. myo-inositol, taurine, glycerophosphocholine, and betaine (4). The intracellular signaling pathways mediating these adaptive mechanisms, especially the role of MAP kinases, are still incompletely understood.

Mitogen-activated protein (MAP) kinase cascades are important intracellular signal-transduction pathways activated in response to changes in osmolality. MAP kinases are serine/threonine kinases activated via a cascade of kinases involving a sequential phosphorylation of two kinases (MAP kinase kinase kinase and MAP kinase kinase), which activates a MAP kinase via a dual phosphorylation on threonine and tyrosine residues (5). In mammalian cells, the MAP kinase family contains three major subgroups responding to distinct extracellular stimuli: extracellular signal-regulated kinases 1 and 2 (ERK) principally activated by growth factors, integrin-matrix interaction, and hormones or neurotransmitters with serpentine receptors (6-12); c-Jun NH2-terminal kinases (JNK, also known as stress-activated protein kinases 1); and p38 kinases (also known as stress-activated protein kinases 2) strongly activated by inflammatory cytokines, ultraviolet light, and hypertonic stress (13-18). To date, the effects of MAP kinases have been mostly attributed to the control of gene transcription via phosphorylation of nuclear transcription factors (5, 13). However, non-genomic effects of MAP kinases are increasingly recognized. ERKs may control glucose metabolism through activation of p90rsk, which phosphorylates and inhibits glycogen synthase kinase 3 (19, 20). In addition, ERKs might be involved in the control of cAMP-specific phosphodiesterase activity (21). On the other hand, p38 kinase might be implicated in stress- and growth factor-induced cytoskeleton reorganization (22, 23) and in the stimulation of glucose transport by insulin (24).

Activation of the three families of MAP kinases by extracellular hypertonicity has been shown in different cell lines in culture (18, 25-29), as well as in native rat MTAL cells (30), but the mechanisms of their activation by extracellular hypertonicity need to be clarified. Neither the respective role of intracellular hypertonicity versus cell shrinkage in the activation of MAP kinases by extracellular hyperosmolality nor the relationship between the MAP kinase activation and the regulatory cell volume increase have been investigated. We have undertaken this study: 1) to examine the effects of different solutes on the activation of MAP kinases in MTAL cells by hypertonicity, and 2) to analyze the relationship between MAP kinase activation and cell volume variations.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Preparation of Single MTALs-- Male Wistar rats weighing 150-200 g were anesthetized with pentobarbital sodium (5 mg/100 g body weight, intraperitoneally) and left kidney was immediately removed after perfusion with ice-cold incubation solution (120 mM NaCl, 5 mM RbCl, 4 mM NaHCO3, 1 mM CaCl2, 1 mM MgSO4, 0.2 mM NaH2PO4, 0.15 mM Na2HPO4, 5 mM glucose, 10 mM lactate, 1 mM pyruvate, 4 mM essential and nonessential amino acids, 0.03 mM vitamin, 20 mM HEPES, and 0.1% bovine serum albumin (BSA), pH 7.4) containing 0.18% (w/v) collagenase. After incubation at 30 °C for 20 min in incubation solution containing 0.05% (w/v) collagenase, kidney slices were stored at 4 °C. Single MTAL were microdissected under stereomicroscopic control in oxygenated (95% O2, 5% CO2) incubation solution.

Preparation of Suspensions of MTALs-- The two kidneys were perfused with ice-cold incubation solution without collagenase. The inner stripes of the outer medulla were excised and minced on ice, and fragments of medullary tubules were obtained by gentle pression through nylon filters with pore size decreasing from 150 to 100 µm. After centrifugation, the pellet was resuspended in ice-cold oxygenated (95% O2, 5% CO2) incubation solution. As controlled under stereomicroscope, MTALs account for about 90% of the tubule fragments in this preparation. Therefore, it will be referred to as MTAL suspension.

Immunoblots-- After preincubation in isotonic incubation solution, MTALs were incubated in isotonic or hypertonic incubation solutions with or without addition of drugs. Incubation was stopped by cooling and centrifugation before addition of ice-cold lysis buffer containing 20 mM Tris-HCl, 2 mM EGTA, 2 mM EDTA, 30 mM NaF, 30 mM Na4O7P2, 2 mM Na3VO4, 1 mM AEBSF, 10 µg/ml leupeptin, 4 µg/ml aprotinin, 1% Triton X-100, pH 7.45. After measurement of protein content by the BCA protein assay (Pierce), equal amounts of protein were separated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Immobilion-P, Millipore). For each experiment, equal transfer of proteins was verified by Ponceau Red staining. Membranes were then blocked in Tris-buffered saline (50 mM Tris, 150 mM NaCl) with 0.2% (v/v) Nonidet P-40 (TBS-Nonidet P-40) and 5% (w/v) nonfat dry milk for 1 h at room temperature and then incubated for 2 h at room temperature with first antibody diluted in TBS-Nonidet P-40 with 5% of milk. Dilutions (v/v) were: 1/1000 for anti-ERK-P and anti-p38-P kinase (New England Biolabs, Beverly, MA); 1/200 for anti-JNK-P; and 1/1000 for anti-ERK and anti-p38 kinase (Santa Cruz Biotechnology, Santa Cruz, CA). The membranes were then washed three times and incubated for 1 h at room temperature with anti-rabbit IgG antibodies coupled to horseradish peroxidase (Transduction Laboratories, Lexington, KY) at dilution 1/10,000 (v/v) in TBS-Nonidet P-40 with 5% milk. After three washes in TBS-Nonidet P-40, immunoreactivity was detected by chemiluminescence using the Super Signal Substrate method (Pierce). Results were quantitated under conditions of linearity by integration of the density of the total area of each band using a video densitometer and the ImageQuant software (Molecular Dynamics). Results are expressed as a percentage of the control optical density (isotonic medium) and are means ± S.E.

Preliminary experiments using ERK activator (phorbol 12,13-dibutyrate) and JNK/p38 kinase activator (anisomycine) have confirmed the specificity of the anti-phospho-MAP kinase antibodies (data not shown).

Determination of MTAL Cellular Volume-- A pool of 3 isolated MTALs was transferred into the concavity of a bacteriological slide coated with dried BSA. After preincubation at 37 °C in isotonic incubation solution, tubules were incubated in isotonic or hypertonic incubation solutions with or without addition of drugs. MTALs were visualized with an inverted microscope and photographies of the same tubules were taken at the end of the preincubation period and after incubation. The MTAL volume was calculated from the measured length and diameter of the tubules (magnification, ×1000). Since in non-perfused tubules, the lumen is collapsed, we assumed that MTAL volume measurement is an appropriate estimate of the MTAL cellular volume. Results are expressed as a percentage of the control volume (end of the preincubation period) and are means ± S.E.

Statistical Analysis-- Differences between two groups were evaluated by Mann-Whitney U test; differences between more groups were evaluated with Kruskall-Wallis test. p values less than 0.05 were considered significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Hypertonic NaCl and Sucrose but Not Urea Increased ERK and p38 Kinase Phosphorylation in MTAL Cells-- MTAL suspensions, as well as microdissected MTALs were incubated for 15 min at 37 °C in isotonic or hypertonic incubation solution. Osmolarity was raised up to 600 mosmol/liter by addition of hypertonic NaCl or sucrose. Fig. 1 shows that hypertonic NaCl and sucrose increased the phosphorylation level of ERK (as percentage of control ± S.E.; NaCl: 295 ± 60%, p < 0.005; sucrose: 975 ± 327%, p < 0.005) and p38 kinase (NaCl: 317 ± 32%, p < 0.01; sucrose: 320 ± 124%, p < 0.005) in microdissected MTALs (Fig. 1A) as well as in MTAL suspensions (Figs. 1, C and D). As depicted in Fig. 1B, the total amounts of ERK and p38 kinase were identical in both preparations, suspensions or microdissected MTALs (Fig. 1, A and C). Thus all subsequent experiments were performed in MTAL suspensions.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of hyperosmolarity on the phosphorylation level of ERK and p38 kinase in suspensions of MTALs and microdissected MTALs. Microdissected and suspensions of mechanically dissociated MTALs were incubated for 15 min at 37 °C under control conditions (C; 300 mosmol/liter) or after addition of either NaCl (N) or sucrose (S) up to 600 mosmol/liter. After cell lysis, proteins were separated by 10% SDS-PAGE and transferred on a polyvinylidene difluoride membrane, and MAP kinases were detected by immunoblot. A, representative immunoblots with phospho-specific antibodies showing the phosphorylation level of ERK and p38 kinase in microdissected MTALs. B, representative immunoblots with anti-ERK2 and anti-p38 kinase antibodies showing the total amounts of ERK and p38 kinase in suspensions of mechanically dissociated MTALs. C, immunoblot of the membrane shown in B with phospho-specific antibodies showing the phosphorylation level of ERK and p38 kinase. D, densitometric quantitation of the phosphorylation level of MAP kinases in MTALs suspensions (shown in C). Results are expressed as a percentage of control and are means ± S.E. from five to six independent experiments (**, p < 0.01; ***, p < 0.005).

Dose Dependence of MAP Kinase Phosphorylation-- The dose dependence of the effect of extracellular osmolarity on MAP kinases phosphorylation was determined by a 15-min incubation of MTAL suspension in solution with osmolarity increasing from 300 to 700 mosmol/liter by addition of NaCl, sucrose, or urea.

As shown in Fig. 2, NaCl-induced extracellular hypertonicity produced a dose-dependent increase of the phosphorylation level of ERK. This effect reached a maximum at 600 mosmol/liter (as percentage of control ± S.E.: 295 ± 60%, p < 0.005). Similarly, the phosphorylation level of p38 kinase was maximally increased at 500 mosmol/liter NaCl (334 ± 45%, p < 0.001). By contrast, the phosphorylation level of JNK was not altered by hypertonic NaCl.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of increasing extracellular osmolarity by addition of NaCl on the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions of MTAL were incubated for 15 min at 37 °C in media with osmolarity increasing from 300 to 700 mosmol/liter by addition of NaCl. Phosphorylated MAP kinases were detected by immunoblot with phosphospecific antibodies. A, representative immunoblot showing the phosphorylation level of ERK, JNK, and p38 kinase in response to increasing extracellular osmolarities. B, densitometric quantitation of the effect of extracellular osmolarity on the phosphorylation level of ERK (filled squares), JNK (filled triangles), and p38 kinase (filled circles). Results are expressed as a percentage of control and are means ± S.E. from six independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.005).

Hypertonic sucrose induced a dose-dependent increase in ERK phosphorylation with a maximum at 600 mosmol/liter (975 ± 327%, p < 0.005) and in p38 kinase phosphorylation with a maximum at 500 mosmol/liter (320 ± 99%, p < 0.005), respectively. In contrast with NaCl, hypertonic sucrose increased JNK phosphorylation with a maximum at 600 mosmol/liter (273 ± 59%, p < 0.005) (Fig. 3).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of increasing osmolarity by sucrose on the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions of MTAL were submitted to the procedure described in Fig. 2, except that osmolarity was increased by addition of sucrose instead of NaCl. A, representative immunoblot showing the phosphorylation level of ERK, JNK, and p38 kinase in response to increasing extracellular osmolarities. B, densitometric quantitation of the effect of extracellular osmolarity on the phosphorylation level of ERK (filled squares), JNK (filled triangles), and p38 kinase (filled circles). Results are expressed as a percentage of control and are means ± S.E. from five independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.005).

Finally, hypertonic urea did not significantly alter the phosphorylation level of MAP kinases (Fig. 4).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of increasing osmolarity by urea on the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions of MTAL were submitted to the procedure described in Fig. 2, except that osmolarity was increased by addition of urea instead of NaCl. A, representative immunoblot showing the phosphorylation level of ERK, JNK, and p38 kinase in response to increasing extracellular osmolarities. B, densitometric quantitation of the effect of extracellular osmolarity on the phosphorylation level of ERK (filled squares), JNK (filled triangles), and p38 kinase (filled circles). Results are expressed as a percentage of control and are means ± S.E. from two independent experiments.

Time Dependence of MAP Kinase Phosphorylation-- To determine the time course of the effect of extracellular osmolarity on phosphorylation of MAP kinases, MTAL suspensions were incubated for a total period of 30 min at 37 °C including adjunction (experimental) or not (control) of a prewarmed hypertonic (NaCl or sucrose up to 600 mosmol/liter) incubation solution for periods varying from 1 to 30 min. Exposure to hypertonic NaCl solution produced an increase in the phosphorylation level of ERK which peaked at 3 min (as percentage of control ± S.E.: 271 ± 61%, p < 0.005) and then progressively decreased to the control level after 30 min (Fig. 5). Similarly, phosphorylation of p38 kinase increased progressively during the first 5 min of incubation to reach a maximum of 404 ± 116% of the control level (p < 0.005). Phosphorylation of p38 kinase then gradually decreased and reached a plateau of 183 ± 84% of the control value after 30 min of incubation. The phosphorylation level of JNK was not significantly altered during the 30-min incubation with hypertonic NaCl.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of incubation time with hypertonic NaCl on the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions of MTAL were incubated for 30 min at 37 °C. Controls were incubated in isotonic medium (300 mosmol/liter), and the other samples were incubated in a medium containing 600 mosmol/liter NaCl for 1-30 min. Phosphorylated MAP kinases were detected by immunoblot with phosphospecific antibodies. A, representative immunoblot showing the phosphorylation level of ERK, JNK, and p38 kinase in response to 600 mosmol/liter NaCl for various times. B, densitometric quantitation of the effect of extracellular osmolarity on the phosphorylation level of ERK (filled squares), JNK (filled triangles), and p38 kinase (filled circles). Results were expressed as a percentage of the control and are means ± S.E. from five independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.005).

With hypertonic sucrose, the ERK phosphorylation increased progressively during the incubation and reached a maximum of 1034 ± 397% of the control level (p < 0.005) at 5 min (Fig. 6). Phosphorylation of p38 kinase increased within the same time course and reached a maximum of 609 ± 237% of the control level (p < 0.005). By contrast with NaCl, we did not observe a progressive decrease in phosphorylation level of both ERK and p38 kinase, which was sustained for 30 min. The phosphorylation level of JNK increased progressively in response to hypertonic sucrose and reached a maximum after 30 min of incubation (as percentage of control ± S.E.: 251 ± 68%, p < 0.05).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of incubation time with hypertonic sucrose on the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions of MTAL were submitted to the procedure described in Fig. 5, except that osmolarity was increased by addition of sucrose instead of NaCl. A, representative immunoblot showing the phosphorylation level of ERK, JNK, and p38 kinase in response to 600 mosmol/liter by addition of sucrose for various times. B, densitometric quantitation of the effect of extracellular osmolarity on the phosphorylation level of ERK (filled squares), JNK (filled triangles), and p38 kinase (filled circles). Results were expressed as a percentage of the control and are means ± S.E. from five independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.005).

Hypertonic NaCl and Sucrose but Not Urea Decreased the Volume of Single MTALs in a Dose- and Time-dependent Manner-- The effects of extracellular hyperosmolarity on the MTAL cellular volume were determined by the following experiments. After a 15-min preincubation period at 37 °C, single MTALs were incubated for 15 min at 37 °C in iso-osmotic or hyperosmotic incubation solutions. Osmolarity was raised up to 600 mosmol/liter by addition of hypertonic NaCl, sucrose, or urea. Fig. 7 shows that hypertonic NaCl and sucrose decreased the MTAL cellular volume. In contrast, urea did not alter MTAL cellular volume.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of hyperosmolarity on the cellular volume of single MTALs. Microdissected single MTALs were incubated for 10 min at 37 °C either under isotonic conditions (C; 300 mosmol/liter) or after addition of NaCl (N), sucrose (S), and urea (U) up to 600 mosmol/liter. Tubules were visualized with an inverted microscope, and photographs were taken before (upper photographs) and after (lower photographs) incubation. A-D, representative photographs showing the effect of incubation in isotonic or hypertonic media on cellular volume. E, quantitation of the effect of extracellular osmolarity on cellular volume. Results are expressed as a percentage of control (initial volume) and are means ± S.E. from four to six independent experiments (**, p < 0.01; ***, p < 0.005).

As shown in Fig. 8A, increasing osmolarity with hypertonic NaCl decreased MTAL cellular volume in a dose-dependent manner with a maximal reduction of 30.64 ± 2.01% of the initial volume (p < 0.001) (Fig. 8A). Similarly, sucrose solution induced a dose-dependent decrease in MTAL cellular volume reaching a 34.92 ± 3.04% reduction from the initial volume (p < 0.05). Over the range of extracellular osmolarity studied, urea did not alter MTAL cellular volume.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 8.   Dose dependence and time course of the effect of extracellular hyperosmolarity on the cellular volume of single MTALs. A, single microdissected MTALs were incubated for 10 min at 37 °C in media with increasing osmolarities (300-700 mosmol/liter) by addition of NaCl (filled squares), sucrose (filled triangles), or urea (filled circles). B, single microdissected MTALs were incubated for 30 min at 37 °C. Controls were incubated in isotonic medium (300 mosmol/liter), and the other samples were incubated in a medium containing 600 mosmol/liter NaCl (filled squares) or sucrose (filled triangles) for 1 to 30 min. Cellular volume was determined as described in legend of Fig. 7. Results are expressed as a percentage of control (initial volume) and are means ± S.E. from four to six independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.005; #, p < 0.001).

For time-course experiments, single MTALs were incubated for a total period of 30 min at 37 °C including adjunction (experimental) or not (control) of a prewarmed hypertonic (NaCl or sucrose up to 600 mosm/liter) incubation solution for periods varying from 1 to 30 min. Fig. 8B shows the time-dependent change in MTAL cellular volume. Increasing incubation time with hypertonic NaCl decreased MTAL cellular volume with a maximal decrease to 68.98 ± 2.21% of the initial volume (p < 0.001) after 10 min of incubation. Increasing incubation time with hyperosmotic NaCl was associated with a progressive recovery of tubule volume that peaked after 30 min of incubation (89.14 ± 2.24%, p < 0.01). Incubation with hypertonic sucrose gave similar results, although the decrease in MTAL cellular volume was slightly more pronounced than with NaCl, reaching 65.47 ± 0.58% of the initial volume (p < 0.001) after 5 min and it was sustained for 15 min. After 30 min of incubation with hypertonic solution, a partial recovery of initial MTAL cellular volume was observed to a lesser extent than with NaCl (81.81 ± 5.94%, p < 0.05).

The Phosphorylation Level of ERK/p38 Kinase Correlated with the MTAL Cellular Volume-- To assess the possibility of a relationship between the phosphorylation level of ERK/p38 kinase and the tubule volume, the changes in phosphorylation level of ERK and p38 kinase were plotted as a function of the variations in MTAL cellular volume.

Fig. 9A, drawn from the data presented in Figs. 2, 3, 5, 6, and 8, shows the linear relationship existing between the phosphorylation level of ERK and the decrease in MTAL cellular volume (r = 0.75). This linear relationship (r = 0.88) was even stronger for p38 kinase (Fig. 9B).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 9.   Correlations between the ERK/p38 kinase phosphorylation and the modifications of the MTAL cellular volume. The variations in phosphorylation level of ERK (A) and p38 kinase (B) determined in suspensions of MTAL were plotted as a function of the modifications in cellular volume of single MTALs incubated under the same conditions. Values are expressed as a percentage of control ± S.E.

Change in Cell Volume Rather than in Osmolarity Was Responsible for the Alteration in Phosphorylation Level of ERK and p38 Kinase-- The following experiments were designed to analyze separately the effects of intracellular hyperosmolarity and cell shrinkage on the increase in phosphorylation level of ERK and p38 kinase.

To induce intracellular hypertonicity without cell volume variation, suspensions or single MTALs were incubated for 9 min in the presence of 10-4 M nystatin (Sigma) in ice-cold isotonic incubation solution (300 mosmol/liter) in which NaCl was substituted for KCl. After three washes in ice-cold isotonic KCl incubation solution, tubules were incubated first in ice-cold hypertonic KCl medium (600 mosmol/liter) for 5 min and then in prewarmed (37 °C) hypertonic NaCl medium (600 mosmol/liter) for 5 additional min. Control experiments have shown that MTAL cellular volume was 94.6 ± 2.1% of its initial value after this procedure. Fig. 10 (A and B) shows that when the MTAL cellular volume decreased, hypertonicity increased the phosphorylation level of ERK and p38 kinase by 269 ± 37% (p < 0.005) and by 179 ± 32% (p < 0.05), respectively. In contrast, when the MTAL cellular volume was maintained constant, intracellular hypertonicity did not alter the phosphorylation level of ERK and p38 kinase.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 10.   Respective role of hyperosmolarity and decreased MTAL cellular volume on the activation of ERK and p38 kinase. Suspensions of MTAL were incubated for 5 min in isotonic (300 mosmol/liter) or hypertonic (600 mosmol/liter) media under conditions where the MTAL cellular volume was kept constant (=) or decreased (downward arrow), as described under "Results." A representative immunoblot shows the phosphorylation level of ERK (A) and p38 kinase (B) according to extracellular osmolarity and cellular volume. The effects of extracellular osmolarity and cellular volume variations on the phosphorylation level of ERK (A) and p38 kinase (B) were quantitated by densitometry. Results are expressed as a percentage of control and are means ± S.E. from six independent experiments (*, p < 0.05; **, p < 0.01; ***, p < 0.005; #, p < 0.001).

A decrease in MTAL cellular volume at constant intracellular osmolality was obtained by 20-min incubation of tubules at 37 °C with 10-4 M nystatin in isotonic incubation solution in which NaCl was substituted for sucrose. This isotonic cell shrinkage was reversed by three washes in isotonic sucrose incubation solution without nystatin followed by a 5-min incubation at 37 °C in isotonic NaCl incubation solution. Control experiments have shown that MTAL cellular volume was 71.1 ± 0.2% of its initial value after incubation with isotonic sucrose plus nystatin, and returned to 102.1 ± 2.0% of its initial value after removal of nystatin and incubation with isotonic NaCl. As depicted in Fig. 10 (A and B), decreasing MTAL cellular volume under isotonic condition increased the phosphorylation level of ERK and p38 kinase by 239 ± 41% (p < 0.001) and 166 ± 20% (p < 0.05), respectively. This effect was reversible upon recovery of initial cellular volume.

p38 Kinase Was Involved in the Regulatory Cell Volume Increase (RVI) of MTAL-- The following experiments were performed to assess the possible role of MAP kinase activation in the RVI of MTAL. After a 15-min preincubation in isotonic NaCl incubation solution with or without 8 × 10-5 M SB203580 (Calbiochem, San Diego, CA), a specific inhibitor of p38 kinase, single MTALs were incubated for 5-30 min with hypertonic NaCl (600 mosmol/liter). Preincubation of tubules with SB203580 did not alter the MTAL cellular volume under isotonic condition. In contrast, SB203580 inhibited the MTAL cellular volume recovery process observed after 30 min of incubation under hypertonic condition (Fig. 11). In contrast, 4 × 10-4 M PD98059 (Calbiochem), a specific inhibitor of ERK pathway, did not alter MTAL cellular volume under isotonic or hypertonic conditions, indicating that ERK is not necessary for cell volume control (data not shown). Control experiments have shown that this concentration of PD98059 prevented the increase in phosphorylation of ERK in response to 600 mosmol/liter extracellular osmolarity.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 11.   Role of p38 kinase in the regulatory cell volume increase of single MTALs. Single microdissected MTALs were incubated for 30 min at 37 °C after a 15-min preincubation with (circles) or without (squares) 8 × 10-5 M SB203580, a specific p38 kinase inhibitor. Controls were incubated with an osmolarity of 300 mosmol/liter (open symbols), and the other samples were incubated with 600 mosmol/liter NaCl for 5-30 min (filled symbols). A, representative photographies showing the effect of SB203580 on MTAL cellular volume before (upper photographs) and after 30 min of incubation at 37 °C (lower photographs) in isotonic (left) or hypertonic (right) media. B, quantitation of the effect of extracellular hyperosmolarity and SB203580 on MTAL cellular volume. Results are expressed as a percentage of control and are means ± S.E. from seven independent experiments (*, p < 0.05).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The present study shows that cell shrinkage induced by extracellular hypertonicity activates MAP kinases in rat MTAL. In addition, our results indicate that, among the MAP kinases, p38 kinase appears to play a major role in the early cell protective response to extracellular hypertonicity, i.e. the RVI.

Extracellular hypertonicity has been shown to activate MAP kinases in various animal cell lines (5), including MDCK cells (26, 27, 31) that share some properties with mammalian distal nephron cells and mIMCD cells (8, 29, 32). Our study, taken with the results of Watts et al. (30), extends this finding to native rat MTAL cells, which are exposed to extracellular osmolarities from 300 to 600 mosmol/liter under water diuresis and antidiuresis, respectively (1). In the present study, the level of phosphorylation of MAP kinases was taken as an index of their activation since only phosphorylated MAP kinases are active (5) and the increase in phosphorylation parallels the activity of MAP kinases in MTAL cells (30). Our results, taken together with a recent study showing that water restriction activates MAP kinases in the rat renal inner medulla (33), support the physiological relevance of the activation of MAP kinases by extracellular hypertonicity.

The major role of MTAL cell shrinkage in the hypertonicity-induced MAP kinases activation is supported by the following observations. 1) Hypertonic urea, which did not alter cellular volume, did not activate MAP kinases; 2) hypertonic sucrose, which induced a larger decrease in cellular volume, was a more powerful activator of ERK and p38 kinases than hypertonic NaCl; 3) cellular volume was inversely correlated with the activation level of ERK and p38 kinases; 4) increased intracellular osmolarity without alteration in cellular volume did not activate ERK and p38 kinase; and 5) cell shrinkage under isotonic conditions was associated with an activation of ERK and p38 kinase, which was reversible upon return to the initial cell volume. These results strongly suggest that cell shrinkage activates the MAP kinases in rat MTAL cells. A role for cell volume variations in the regulation of cellular signaling pathways has already been demonstrated in human polymorphonuclear cells (34).

Since hyperosmolarity activates MAP kinases through changes in cellular volume, the hypothesis that components of the cytoskeleton may be the primary sensor should be considered. Moreover, extracellular hypertonicity drives water movement outside the cells leading to an increase in cytoplasmic concentration of macromolecules, which could play the role of volume sensor (2). Finally, aggregation of growth factor and cytokine receptors leading to their ligand-independent activation could participate to the activation of MAP kinases by hypertonicity via membrane-based sensors (18). Indeed, hypertonicity increases tyrosine phosphorylation of cellular proteins in human polymorphonuclear cells (34) and in Chinese hamster ovary cells (35) and the activation of ERK and p38 kinase is tyrosine kinase-dependent in rat MTAL cells (30).

Whereas both MTAL and IMCD cells are exposed to extracellular hypertonicity, comparison of the activation pattern of MAP kinases reveals a cellular specificity. In agreement with Watts et al. (30), our study shows that in MTAL cells, JNK is not activated by hypertonic NaCl, in contrast with the marked activation of JNK by hypertonic NaCl in mIMCD cells (VC52, VC18). Nevertheless, hypertonic sucrose stimulated JNK by about 2-fold in MTAL cells. However, JNK activation was considerably lower than stimulation of both ERK (about 10-fold) and p38 kinase (about 4-fold). This higher activation level of MAP kinases might be related to the more pronounced cell shrinkage induced by hypertonic sucrose as compared with hypertonic NaCl. In MTAL cells, cell shrinkage may induce a sequential activation of MAP kinases pathway, with a more sensitive response of ERK and p38 kinase pathways.

The RVI is an essential mechanism of cellular protection against osmotic stress. After the initial cell shrinkage, MTAL cells exhibit a RVI response that involves the activation of ion transporters (3). This process drives sodium influx coupled to secondary water movements into the cells and allows the partial recovery of the initial cell volume (2). Our results confirm that MTAL cells undergo RVI after an hypertonic challenge (3) with NaCl and sucrose, and show that p38 kinase activation is required for this process, while ERK pathway does not appear to play a role. Whether p38 kinase activates ion transporters through direct phosphorylation or involves intermediate steps remains to be determined. Among them, one can postulate a role for a p38-dependent cytoskeletal remodeling (22).

In conclusion, we have shown that, in rat MTAL cells, hypertonic extracellular medium activates ERK and p38 kinase and in a lesser extent JNK. This activation was not the direct consequence of an increase in intracellular osmolarity, but was mediated by cell shrinkage. In addition, this study demonstrates that activation of p38 kinase is essential in the regulatory cell volume increase process, a cell protection mechanism against the physiological hyperosmolarity of the rat kidney medulla.

    ACKNOWLEDGEMENT

We thank Dr. S. Gonin for critical reading of the manuscript.

    FOOTNOTES

* This work was supported in part by Grant 31-50-643.97 from the Swiss National Science Research Foundation (to H. F. and E. F.) and by a grant from the Société Académique de Genève (to E. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 41-22-382-38-37; Fax: 41-22-347-59-79; E-mail: feraille@cmu.unige.ch.

    ABBREVIATIONS

The abbreviations used are: MTAL, medullary thick ascending limb of Henle; AEBSF, [4-(2-aminoethyl)-benzenesulfonylfluoride)]; BSA, bovine serum albumin; ERK, extracellular signal-regulated kinase; JNK, c-Jun NH2-terminal kinase; PAGE, polyacrylamide gel electrophoresis; RVI, regulatory volume increase; TBS, Tris-buffered saline; MAP, mitogen-activated protein; MAPK, mitogen-activated protein kinase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Knepper, M. A., and Rector, F. C., Jr. (1996) in The Kidney (Brenner, B. M., ed), 5th Ed. , pp. 532-570, W. B. Saunders Co., Philadelphia
2. Parker, J. C. (1993) Am. J. Physiol. 265, C1191-C1200[Abstract/Free Full Text]
3. Sun, A. M., Saltzberg, S. N., Kikeri, D., and Hebert, S. C. (1990) Kidney Int. 38, 1019-1029[Medline] [Order article via Infotrieve]
4. Burg, M. B. (1995) Am. J. Physiol. 268, F983-F996[Abstract/Free Full Text]
5. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L. (1999) Physiol. Rev. 79, 143-180[Abstract/Free Full Text]
6. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J., and Sturgill, T. W. (1993) Science 262, 1065-1072[Abstract/Free Full Text]
7. Graves, L. M., Bornfeldt, K. E., Raines, E. W., Potts, B. C., MacDonald, S. G., Ross, R., and Krebs, E. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10300-10304[Abstract/Free Full Text]
8. Ferby, I. M., Waga, I., Sakanaka, C., Kume, K., and Shimizu, T. (1994) J. Biol. Chem. 269, 30485-30488[Abstract/Free Full Text]
9. Morino, N., Mimura, T., Hamasaki, K., Tobe, K., Ueki, K., Kikuchi, K., Takehara, K., Kadowaki, T., Yazaki, Y., and Nojima, Y. (1995) J. Biol. Chem. 270, 269-273[Abstract/Free Full Text]
10. Flordellis, C. S., Berguerand, M., Gouache, P., Barbu, V., Gavras, H., Handy, D. E., Béréziat, G., and Masliah, J. (1995) J. Biol. Chem. 270, 3491-3494[Abstract/Free Full Text]
11. Crespo, P., Xu, N., Simmonds, W. S., and Gutkind, J. S. (1994) Nature 369, 418-420[CrossRef][Medline] [Order article via Infotrieve]
12. Liao, D.-F., Monia, B., Dean, N., and Berk, B. C. (1997) J. Biol. Chem. 272, 6146-6150[Abstract/Free Full Text]
13. Ip, T., and Davis, R. J. (1998) Curr. Opin. Cell Biol. 10, 205-219[CrossRef][Medline] [Order article via Infotrieve]
14. Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Hsuan, J., and Saklatvala, J. (1994) Cell 78, 1039-1049[CrossRef][Medline] [Order article via Infotrieve]
15. Sluss, H. K., Barrett, T., Dérijard, B., and Davis, R. J. (1994) Mol. Cell. Biol. 14, 8376-8384[Abstract/Free Full Text]
16. Matsuda, S., Kawasaki, H., Moriguchi, T., Gotoh, Y., and Nishida, E. (1995) J. Biol. Chem. 270, 12781-12786[Abstract/Free Full Text]
17. Chen, Y.-R., Wang, X., Templeton, D., Davis, R. J., and Tan, T.-H. (1996) J. Biol. Chem. 271, 31929-31936[Abstract/Free Full Text]
18. Rosette, C., and Karin, M. (1996) Science 274, 1194-1197[Abstract/Free Full Text]
19. Eldar-Finkelman, H., Seger, R., Vandenheede, R., and Krebs, E. G. (1995) J. Biol. Chem. 270, 987-990[Abstract/Free Full Text]
20. Chang, P.-Y., Le Marchand-Brustel, Y., Cheatham, L. A., and Moller, D. E. (1995) J. Biol. Chem. 270, 29928-29935[Abstract/Free Full Text]
21. Liu, H., and Maurice, D. H. (1999) J. Biol. Chem. 274, 10557-10565[Abstract/Free Full Text]
22. Huot, J., Houle, F., Rousseau, S., Deschesnes, R. G., Shah, G. M., and Landry, J. (1998) J. Cell Biol. 143, 1361-1373[Abstract/Free Full Text]
23. Matsumoto, T., Yokote, K., Tamura, K., Takemoto, M., Ueno, H., Saito, Y., and Mori, S. (1999) J. Biol. Chem. 274, 13954-13960[Abstract/Free Full Text]
24. Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A., and Klip, A. (1999) J. Biol. Chem. 274, 10071-10078[Abstract/Free Full Text]
25. Galcheva-Gargova, Z., Dérijard, B., Wu, I.-H., and Davis, R. J. (1994) Science 265, 806-811[Abstract/Free Full Text]
26. Itoh, T., Yamauchi, A., Miyai, A., Yokoyama, K., Kamada, T., Ueda, N., and Fujiwara, Y. (1994) J. Clin. Invest. 93, 2387-2392
27. Terada, Y., Tomita, K., Homma, M. K., Nonoguchi, H., Yang, T., Yamada, T., Yuasa, Y., Krebs, E. G., Sasaki, S., and Marumo, F. (1994) J. Biol. Chem. 269, 31296-31301[Abstract/Free Full Text]
28. Zhang, Z., and Cohen, D. M. (1996) Am. J. Physiol. 271, F1234-F1238[Abstract/Free Full Text]
29. Berl, T., Siriwardana, G., Ao, L., Butterfield, L. M., and Heasley, L. E. (1997) Am. J. Physiol. 272, F305-F311[Abstract/Free Full Text]
30. Watts, B. A. I., Di Mari, J. F., Davis, R. J., and Good, D. W. (1998) Am. J. Physiol. 275, F478-F486[Abstract/Free Full Text]
31. Sheikh-Hamad, D., Di Mari, J., Suki, W. N., Safirstein, R., Watts, B. A., III., and Rouse, D. (1998) J. Biol. Chem. 273, 1832-1837[Abstract/Free Full Text]
32. Kültz, D., Madhany, S., and Burg, M. B. (1998) J. Biol. Chem. 273, 13645-13651[Abstract/Free Full Text]
33. Wojtaszek, P. A., Heasley, L. E., and Berl, T. (1998) J. Clin. Invest. 102, 1874-1881[Medline] [Order article via Infotrieve]
34. Krump, E., Nikitas, K., and Grinstein, S. (1997) J. Biol. Chem. 272, 17303-17311[Abstract/Free Full Text]
35. Kapus, A., Szaszi, K., Sun, J., Rizoli, S., and Rotstein, O. D. (1999) J. Biol. Chem. 274, 8093-8102[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
U. Hasler
Controlled aquaporin-2 expression in the hypertonic environment
Am J Physiol Cell Physiol, April 1, 2009; 296(4): C641 - C653.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen
Physiology of Cell Volume Regulation in Vertebrates
Physiol Rev, January 1, 2009; 89(1): 193 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Inagaki, E. Omori, J.-Y. Kim, Y. Komatsu, G. Scott, M. K. Ray, G. Yamada, K. Matsumoto, Y. Mishina, and J. Ninomiya-Tsuji
TAK1-binding Protein 1, TAB1, Mediates Osmotic Stress-induced TAK1 Activation but Is Dispensable for TAK1-mediated Cytokine Signaling
J. Biol. Chem., November 28, 2008; 283(48): 33080 - 33086.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Hasler, P. Nunes, R. Bouley, H. A. J. Lu, T. Matsuzaki, and D. Brown
Acute Hypertonicity Alters Aquaporin-2 Trafficking and Induces a MAPK-dependent Accumulation at the Plasma Membrane of Renal Epithelial Cells
J. Biol. Chem., September 26, 2008; 283(39): 26643 - 26661.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M.-B. Nielsen, S. T. Christensen, and E. K. Hoffmann
Effects of osmotic stress on the activity of MAPKs and PDGFR-{beta}-mediated signal transduction in NIH-3T3 fibroblasts
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1046 - C1055.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva
Cellular Response to Hyperosmotic Stresses
Physiol Rev, October 1, 2007; 87(4): 1441 - 1474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. K. Hoffmann and S. F. Pedersen
Shrinkage insensitivity of NKCC1 in myosin II-depleted cytoplasts from Ehrlich ascites tumor cells
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1854 - C1866.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Xu, R. T. Worrell, H. C. Li, S. L. Barone, S. Petrovic, H. Amlal, and M. Soleimani
Chloride/Bicarbonate Exchanger SLC26A7 Is Localized in Endosomes in Medullary Collecting Duct Cells and Is Targeted to the Basolateral Membrane in Hypertonicity and Potassium Depletion
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 956 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. B. Friis, C. R. Friborg, L. Schneider, M.-B. Nielsen, I. H. Lambert, S. T. Christensen, and E. K. Hoffmann
Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts
J. Physiol., September 1, 2005; 567(2): 427 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
W. S. Marshall, C. G. Ossum, and E. K. Hoffmann
Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium
J. Exp. Biol., March 15, 2005; 208(6): 1063 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Zhao, R. Hyde, and H. S Hundal
Signalling mechanisms underlying the rapid and additive stimulation of NKCC activity by insulin and hypertonicity in rat L6 skeletal muscle cells
J. Physiol., October 1, 2004; 560(1): 123 - 136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. S. Lang, S. Myssina, P. A. Lang, V. Tanneur, D. S. Kempe, A. F. Mack, S. M. Huber, T. Wieder, F. Lang, and C. Duranton
Inhibition of erythrocyte phosphatidylserine exposure by urea and Cl-
Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1046 - F1053.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Myssina, S. M. Huber, C. Birka, P. A. Lang, K. S. Lang, B. Friedrich, T. Risler, T. Wieder, and F. Lang
Inhibition of Erythrocyte Cation Channels by Erythropoietin
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2750 - 2757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Bustamante, F. Roger, M.-L. Bochaton-Piallat, G. Gabbiani, P.-Y. Martin, and E. Feraille
Regulatory volume increase is associated with p38 kinase-dependent actin cytoskeleton remodeling in rat kidney MTAL
Am J Physiol Renal Physiol, August 1, 2003; 285(2): F336 - F347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Lang, C. Weigert, S. Braedel, S. Fillon, M. Palmada, E. Schleicher, H.-G. Rammensee, and F. Lang
Inhibition of interferon-gamma expression by osmotic shrinkage of peripheral blood lymphocytes
Am J Physiol Cell Physiol, January 1, 2003; 284(1): C200 - C208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. A. Steinbrecher, J. A. Rudolph, G. Luo, and M. B. Cohen
Coordinate upregulation of guanylin and uroguanylin expression by hypertonicity in HT29-18-N2 cells
Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1729 - C1737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-R. Shen, C.-Y. Chou, K.-F. Hsu, and J. C. Ellory
Osmotic Shrinkage of Human Cervical Cancer Cells Induces an Extracellular Cl--dependent Nonselective Cation Channel, Which Requires p38 MAPK
J. Biol. Chem., November 22, 2002; 277(48): 45776 - 45784.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zayzafoon, S. Botolin, and L. R. McCabe
p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose
J. Biol. Chem., September 27, 2002; 277(40): 37212 - 37218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Startchik, D. Morabito, U. Lang, and M. F. Rossier
Control of Calcium Homeostasis by Angiotensin II in Adrenal Glomerulosa Cells through Activation of p38 MAPK
J. Biol. Chem., June 28, 2002; 277(27): 24265 - 24273.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen and D. G. Gardner
Osmoregulation of Natriuretic Peptide Receptor Signaling in Inner Medullary Collecting Duct. A REQUIREMENT FOR p38 MAPK
J. Biol. Chem., February 15, 2002; 277(8): 6037 - 6043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. G. Goss, L. Jiang, D. H. Vandorpe, D. Kieller, M. N. Chernova, M. Robertson, and S. L. Alper
Role of JNK in hypertonic activation of Cl--dependent Na+/H+ exchange in Xenopus oocytes
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1978 - C1990.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Tian, Z. Zhang, and D. M. Cohen
MAPK signaling and the kidney
Am J Physiol Renal Physiol, October 1, 2000; 279(4): F593 - F604.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. P. Yu and D. W. Choi
Ions, cell volume, and apoptosis
PNAS, August 15, 2000; 97(17): 9360 - 9362.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Maeno, Y. Ishizaki, T. Kanaseki, A. Hazama, and Y. Okada
Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis
PNAS, July 12, 2000; (2000) 140216197.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Maeno, Y. Ishizaki, T. Kanaseki, A. Hazama, and Y. Okada
From the Cover: Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis
PNAS, August 15, 2000; 97(17): 9487 - 9492.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roger, F.
Right arrow Articles by Féraille, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roger, F.
Right arrow Articles by Féraille, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement